Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Baxter
Merck
Daiichi Sankyo
Harvard Business School
Cerilliant
Dow
Johnson and Johnson
Express Scripts
Cipla

Generated: August 18, 2017

DrugPatentWatch Database Preview

ARTANE Drug Profile

« Back to Dashboard

What is the patent landscape for Artane, and when can generic versions of Artane launch?

Artane is a drug marketed by Lederle and is included in two NDAs.

The generic ingredient in ARTANE is trihexyphenidyl hydrochloride. There are three drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the trihexyphenidyl hydrochloride profile page.

Summary for Tradename: ARTANE

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list66
Clinical Trials: see list1
Patent Applications: see list1,312
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ARTANE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle
ARTANE
trihexyphenidyl hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL012947-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lederle
ARTANE
trihexyphenidyl hydrochloride
TABLET;ORAL006773-005Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Lederle
ARTANE
trihexyphenidyl hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL006773-010Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lederle
ARTANE
trihexyphenidyl hydrochloride
ELIXIR;ORAL006773-009Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lederle
ARTANE
trihexyphenidyl hydrochloride
TABLET;ORAL006773-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Fuji
McKinsey
Mallinckrodt
Citi
Argus Health
Novartis
Julphar
Baxter
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot